Company_Context
Healthcare
Laboratory Analytical Instruments
Institutional analysis of internal capital flows based on SEC Form 4 filings.
Signal_Window
Headline metrics use exact calendar-day windows.
57 directional transactions in 90D
Code P purchases and code S sales are measured from 2026.05.31 — 2026.08.28.
-$332.9M
Open-market buys minus sales2026.08.21
Latest available filing7
Reporting entities in windowNo 90D buyer
No open-market buys in 90DMeister Keith A.
$332.2MAnalysis of eligible SEC Form 4 activity for ILMN indicates a bearish 90-day signal. The selected window contains transactions from 7 distinct reporting insiders, with aggregate nominal activity of $334.08M.
Open-market purchases minus open-market sales produce a negative net flow of $332.86M. Open-market executions represent the majority of measured nominal activity in this window, making the directional flow more representative of voluntary trading activity.
The largest open-market sale in the selected window was attributed to Meister Keith A.. Form 4 activity provides useful ownership context, but it should not be treated as a standalone prediction of future price performance.
Enriched_Research_Context
These indicators use normalized SEC roles, issuer metadata, cluster detection and post-filing market prices already calculated by the data pipeline.
Healthcare
Laboratory Analytical Instruments
0
Clustered open-market purchase records in the recent filing sample.
Recent_Filing_History
This table shows recent filing history and is not restricted by the selected 90D headline signal window.
The selected 90-day window contains 7 distinct reporting insiders with eligible transactions for ILMN. This count changes when a different signal window is selected.
Open-market selling volume ($332.86M) currently exceeds buying volume ($0.00M), indicating net liquidation by insiders.
No eligible open-market purchases were reported for ILMN during the last 90 calendar days.
Leckman Patricia
OPEN_MARKET_SALEOther Officer · 2026.06.05
30D
+19.7%
90D
PENDING
180D
PENDING
Performance uses the latest matured open-market record in this sample. It describes subsequent market movement and does not imply that the filing caused the price change.